Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Survival of women with ovarian carcinomas and borderline tumors is not affected by estrogen and progesterone receptor status.

Sallum LF, Sarian LO, Lucci De Angelo Andrade L, Vassallo J, Soares FA, Pinto GA, Ferreira PA, Derchain S.

J Gynecol Oncol. 2013 Apr;24(2):167-76. doi: 10.3802/jgo.2013.24.2.167. Epub 2013 Apr 5.

PMID:
23653835
[PubMed]
Free PMC Article
2.

Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.

Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK.

Oncol Rep. 2007 Nov;18(5):1051-9.

PMID:
17914554
[PubMed - indexed for MEDLINE]
3.

Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.

Yasunaga M, Ohishi Y, Oda Y, Misumi M, Iwasa A, Kurihara S, Nishimura I, Okuma E, Kobayashi H, Wake N, Tsuneyoshi M.

Hum Pathol. 2009 Jul;40(7):965-74. doi: 10.1016/j.humpath.2008.12.006. Epub 2009 Mar 9.

PMID:
19269675
[PubMed - indexed for MEDLINE]
5.

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.

Lax SF, Pizer ES, Ronnett BM, Kurman RJ.

Hum Pathol. 1998 Jun;29(6):551-8.

PMID:
9635673
[PubMed - indexed for MEDLINE]
6.

Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases.

Vang R, Gown AM, Barry TS, Wheeler DT, Ronnett BM.

Mod Pathol. 2006 Jan;19(1):97-105.

PMID:
16294196
[PubMed - indexed for MEDLINE]
Free Article
7.

Analysis of the contribution of immunologically-detectable HER2, steroid receptors and of the "triple-negative" tumor status to disease-free and overall survival of women with epithelial ovarian cancer.

de Toledo MC, Sarian LO, Sallum LF, Andrade LL, Vassallo J, de Paiva Silva GR, Pinto GA, Soares FA, Fonseca CD, Derchain SF.

Acta Histochem. 2014 Apr;116(3):440-7. doi: 10.1016/j.acthis.2013.09.010. Epub 2013 Nov 12.

PMID:
24238473
[PubMed - in process]
8.

Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma.

Fujimura M, Hidaka T, Kataoka K, Yamakawa Y, Akada S, Teranishi A, Saito S.

Am J Surg Pathol. 2001 May;25(5):667-72.

PMID:
11342781
[PubMed - indexed for MEDLINE]
9.

[Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].

Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.

Zhonghua Fu Chan Ke Za Zhi. 2007 Apr;42(4):227-32. Chinese.

PMID:
17631760
[PubMed - indexed for MEDLINE]
10.

EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.

Fischer-Colbrie J, Witt A, Heinzl H, Speiser P, Czerwenka K, Sevelda P, Zeillinger R.

Anticancer Res. 1997 Jan-Feb;17(1B):613-9.

PMID:
9066588
[PubMed - indexed for MEDLINE]
11.
12.

[Expression of heat shock protein-70, estrogen receptor and progesterone receptor in ovarian carcinomas and the correlation between HSP70 and sex steroid receptor].

Xing Y, Tang Z, Liao Y, Zhu SF, Li ZM, Chen ML.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Jul;35(4):486-8. Chinese.

PMID:
15291106
[PubMed - indexed for MEDLINE]
13.

[Expression and promotor methylation of p73 gene in ovarian epithelial tumors].

Zhang YL, Guo XR, Shen DH, Cheng YX, Liang XD, Chen YX, Wang Y.

Zhonghua Bing Li Xue Za Zhi. 2012 Jan;41(1):33-8. Chinese.

PMID:
22455848
[PubMed - indexed for MEDLINE]
14.

Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.

Shabani N, Mylonas I, Jeschke U, Thaqi A, Kuhn C, Puchner T, Friese K.

Anticancer Res. 2007 Jul-Aug;27(4A):2027-33.

PMID:
17649817
[PubMed - indexed for MEDLINE]
Free Article
15.

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM.

J Natl Cancer Inst. 2005 Sep 7;97(17):1254-61.

PMID:
16145046
[PubMed - indexed for MEDLINE]
Free Article
16.

Steroid hormone receptors and long term survival in invasive ovarian cancer.

Münstedt K, Steen J, Knauf AG, Buch T, von Georgi R, Franke FE.

Cancer. 2000 Oct 15;89(8):1783-91.

PMID:
11042574
[PubMed - indexed for MEDLINE]
17.

[Expression of folate receptor alpha in ovarian epithelial tumors].

Shen DH, Xie JL, Zhang YL, Wang Y.

Zhonghua Bing Li Xue Za Zhi. 2010 Nov;39(11):747-51. Chinese.

PMID:
21215165
[PubMed - indexed for MEDLINE]
18.

Prognostic value of estrogen receptor and progesterone receptor status in young Chinese ovarian carcinoma patients.

Yang XY, Xi MR, Yang KX, Yu H.

Gynecol Oncol. 2009 Apr;113(1):99-104. doi: 10.1016/j.ygyno.2008.12.018. Epub 2009 Jan 29.

PMID:
19178934
[PubMed - indexed for MEDLINE]
19.
20.

Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.

Lee YH, Heo JH, Kim TH, Kang H, Kim G, Kim J, Cho SH, An HJ.

Int J Gynecol Pathol. 2011 May;30(3):205-17. doi: 10.1097/PGP.0b013e3182063e71.

PMID:
21464733
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk